Tinea Corporis
📧 Sign up to get email alerts when something new happens for Tinea Corporis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis [Phase 4]
A Phase 4 clinical trial comparing oral fluconazole with oral itraconazole for resistant tinea corporis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: A Pilot Study to Evaluate the Therapeutic Efficacy of Intra-Lesional Immunotherapy in Patients Aged 10-60 Years With Recalcitrant Tinea Cruris and Corporis [NA]
A pilot clinical trial evaluates the therapeutic efficacy of intra-lesional immunotherapy for recalcitrant tinea corporis and tinea cruris i…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Efficacy of Ultraviolet B Phototherapy in the Management of Resistant and Relapsing Tinea Corporis and Tinea Cruris [NA]
A Cairo University-sponsored study is evaluating UV-B phototherapy for resistant and relapsing tinea corporis and tinea cruris, with the tri…
-
FDA approval · 2025-09-12FDA Approved: TERBINAFINE HYDROCHLORIDE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Terbinafine hydrochloride from Bionpharma Inc., approving a generic antifungal product under the…
-
FDA approval · 2025-03-20FDA Approved: ULTRAMICROSIZE GRISEOFULVIN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for Ultramicrosize Griseofulvin tablets from Amneal Pharmaceuticals of New York LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-03-07FDA Approved: KETOCONAZOLE — Original Application (Viona Pharmaceuticals Inc)
FDA approves the Original Application for Ketoconazole submitted by Viona Pharmaceuticals Inc, granting approval of a generic ketoconazole p…
-
FDA label_change · 2025-03-06FDA Approved: CICLOPIROX OLAMINE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for Ciclopirox Olamine filed by Padagis Israel Pharmaceuticals Ltd, resulting in changes to the prod…
-
FDA approval · 2024-12-20FDA Approved: TERBINAFINE HYDROCHLORIDE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)
FDA approved a supplemental application for a generic Terbinafine hydrochloride product from Breckenridge Pharmaceutical, Inc.
-
FDA approval · 2024-09-16FDA Approved: KETOCONAZOLE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' original application for a generic ketoconazole product.
-
FDA approval · 2024-02-29FDA Approved: CLOTRIMAZOLE — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved the original application for clotrimazole from Rising Pharma Holdings, enabling a generic version of this antifungal. It co…
-
FDA approval · 2023-10-16FDA Approved: CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% — Original Application (Allegis Holdings, LLC)
The FDA approved Allegis Holdings' clotrimazole topical solution 1% under an Original Application (ANDA), making a generic clotrimazole topi…
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: Efficacy and Safety of Terbinafine and Itraconazole [Phase 2, Phase 3]
Phase 2/3 trial update on terbinafine and itraconazole for dermatophytoses including tinea corporis and tinea cruris; efficacy and safety da…
-
FDA approval · 2022-03-04FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved an Original Application for a generic Nystatin and Triamcinolone Acetonide topical product from Alembic Pharmaceuticals Inc.
-
FDA approval · 2021-11-12FDA Approved: NAFTIFINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for naftifine hydrochloride submitted by Sun Pharmaceutical Industries, Inc. This action updates…
-
FDA approval · 2021-05-21FDA Approved: KETOCONAZOLE — Original Application (Xiromed, LLC)
FDA has approved Xiromed, LLC's original generic application for Ketoconazole Foam, a topical antifungal 2% product.
-
FDA approval · 2021-05-20FDA Approved: KETOCONAZOLE — Original Application (Encube Ethicals, Inc.)
FDA approves Encube Ethicals' ketoconazole cream, 2% as an original-application generic topical antifungal product (ANDA212443).
-
FDA approval · 2020-07-06FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma's supplemental approval for the clotrimazole and betamethasone dipropionate topical product. The action approves…
-
FDA approval · 2020-07-06FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (NORTHSTAR RX LLC)
FDA approved a supplemental application for clotrimazole and betamethasone dipropionate topical from NorthStar RX LLC.
-
FDA approval · 2020-05-29FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (Glenmark Pharmaceuticals Inc. USA)
FDA approved a supplemental application for clotrimazole and betamethasone dipropionate from Glenmark Pharmaceuticals USA, authorizing an up…
-
FDA label_change · 2020-04-09FDA Approved: NAFTIN — Supplemental Application (Legacy Pharma USA Inc.)
FDA approved a supplemental application for NAFTIN (naftifine hydrochloride) from Legacy Pharma USA Inc. to update the product labeling.
-
FDA approval · 2020-02-18FDA Approved: KETOCONAZOLE — Supplemental Application (THIRTY MADISON INC)
The FDA approved a supplemental application for Ketoconazole filed by Thirty Madison Inc, resulting in updates to the Ketoconazole product l…
-
FDA approval · 2019-12-03FDA Approved: NAFTIFINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for naftifine hydrochloride from Sun Pharmaceutical Industries, Inc.
-
FDA label_change · 2019-12-03FDA Approved: NAFTIFINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for naftifine hydrochloride from Sun Pharmaceutical Industries, Inc., updating the labeling for …
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Safety and Efficacy of Product 33525 (Luliconazole Cream 1%) in Pediatric Participants With Tinea Corporis [Phase 4]
Phase 4 trial update evaluating safety and efficacy of luliconazole 1% cream in pediatric participants with Tinea Corporis; completed with p…
-
FDA label_change · 2019-10-28FDA Approved: NAFTIFINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a Sun Pharmaceutical supplemental application for Naftifine Hydrochloride, updating the product labeling for the topical antifu…